Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A unique class of RNA drugs could bring new treatments to cancer and other diseases.
Monsanto and others look to RNA interference to fight widespread bee-killing mites.
The decision should reduce uncertainty in the field of molecular diagnostics.
The technique could help patients with currently untreatable diseases such as Huntington’s.
A biotech company founded by Craig Mello, codiscoverer of RNAi, brings its first self-delivering interfering RNA to clinical trial.
A new study reveals the influence of large RNA molecules in controlling stem cells.
Repetitive stretches of RNA are found in high concentrations in cancer cells.
Using RNA instead of DNA could avoid the health risks–and the political pitfalls–of stem-cell treatments.
A new type of genetic switch gives bioengineers better control over microbes.